ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986

Review Of NTP Could Lead To Administrative Changes

April 18, 1980

PSA Level Predicts Survival For Prostate Cancer

October 25, 2002

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

IOM To Form Committee To Investigate Duke Genomics Research

October 1, 2010

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992